Publication: The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria
Issued Date
2020-10-01
Resource Type
ISSN
18790364
13695274
13695274
Other identifier(s)
2-s2.0-85094837587
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Current Opinion in Microbiology. Vol.57, (2020), 95-101
Suggested Citation
Susanna J. Dunachie, Nicholas PJ Day, Christiane Dolecek The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria. Current Opinion in Microbiology. Vol.57, (2020), 95-101. doi:10.1016/j.mib.2020.09.013 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/59987
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria
Other Contributor(s)
Abstract
© 2020 The Authors Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR.